Reply To: Biotene

  • Julie Moreton

    Member
    September 28, 2019 at 7:04 pm

    1) Do you limit it to your most at-risk populations? No, all HemeOnc patients with central lines have it ordered. We have not spread this particular practice to other units though
    2) What is your dosing frequency? Ordered QID
    3) What is your dosing amount? 5mL
    4) How is its use documented? Biotene is on our eMAR
    5) Do you have internal data about its impact on mucositis severity and/or CLABSIs/MBI-CLABSIs vs. the standard of care prior to Biotene? We do not have any control data with HO patients unfortunately

    ——————————
    Julie Moreton, MSN RN CPHON CPN CLNC
    President, Palmetto-APHON Chapter
    Nursing Education Specialist
    Prisma Health Children’s Hospital – Midlands
    Columbia, SC
    ——————————
    ——————————————-
    Original Message:
    Sent: 09-16-2019 11:14 AM
    From: Chris Donaghey
    Subject: Biotene

    Hi all,

    I’ve revisited oral rinses in a handful of ways over the years. And I’ve seen Biotene mentioned by a more than a few of your facilities as the oral rinse of choice for your kiddos.

    If your facility uses Biotene, could you answer the following questions:

    1) Do you limit it to your most at-risk populations?
    2) What is your dosing frequency?
    3) What is your dosing amount?
    4) How is its use documented?
    5) Do you have internal data about its impact on mucositis severity and/or CLABSIs/MBI-CLABSIs vs. the standard of care prior to Biotene? If so, I’m interested.

    Thanks for the input!

    ——————————
    Chris Donaghey, MSN, RN, PCNS-BC, CPN, CPHON
    Clinical Nurse Specialist – Riley Cancer Center
    Riley Hospital for Children at IU Health
    Indianapolis, IN
    ——————————